WTW
Willis Towers Watson Public Limited Company329.76
-1.01-0.31%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Specialties offset pricing; Medicare short-term drag.
Q&A reinforced prepared optimism on 2026 mid-single-digit growth, spotlighting R&B specialties like electrification and data centers offsetting pricing softness for mid-to-high single-digits. Health targets high single-digits from over 10% global inflation plus new wins; career mid-single-digits via recurring advisory and AI redesign work. BD&O's low single-digit guide stems from short-term Medicare shifts, deemed neutral long-term with retiree upside. Specialties trump pricing woes. Management directly tackled pricing and Medicare probes with specifics. Bullish tone intact; watch talent hires and Medicare rebound.
Key Stats
Market Cap
32.17BP/E (TTM)
15.80Basic EPS (TTM)
20.87Dividend Yield
0.01%Recent Filings
10-K
FY2025 results
Willis Towers Watson posted FY2025 revenue of $9.7B, down 2% as-reported but up 5% organically, reflecting strong momentum after shedding TRANZACT while HWC and R&B both grew organically 4% and 7%. Q4 drove acceleration with robust broking new business and specialties, plus HWC gains in Health international and Retirement, yielding adjusted operating income steady at $2.4B (25% margin) despite the divestiture. Net income swung to $1.6B profit from a $98M loss, boosted by no repeat of prior impairments and transformation costs. Debt stood at $6.3B with $1.5B revolver capacity; $1.6B share repurchases left $1.3B authorized, alongside $358M dividends. Data breaches could disrupt quarterly client delivery.
8-K
Organic growth, margin gains shine
WTW reported Q4 revenue down 3% to $2.9B and full-year down 2% to $9.7B due to TRANZACT sale, yet organic growth hit 6% quarterly and 5% annually. Adjusted diluted EPS rose 2% to $8.12 in Q4 and 5% to $17.08 yearly, with margins expanding. Free cash flow jumped $279M to $1.55B. Share repurchases totaled $1.65B.
8-K
WTW completes Newfront acquisition
WTW completed its acquisition of Newfront Insurance Holdings on January 27, 2026, folding the San Francisco-based broker into its Risk & Broking and Health, Wealth & Career segments. This bolsters U.S. middle-market reach and high-growth sectors like tech and life sciences via Newfront's AI-driven platform. Integration underway. Effective integration remains key amid execution risks.
8-K
WTW inks $775M acquisition loan
WTW secured a $775M delayed-draw term loan on January 7, 2026, maturing three years from first draw or two months post-Newfront Acquisition close. Funds will finance part of the Newfront deal, refinance debt, and support working capital. Unsecured with SOFR-based rates plus 62.5bps-1.25% margins. Commitments expire six months after close.
8-K
WTW issues $1B notes
Willis Towers Watson's Willis North America completed a $1 billion senior notes offering on December 22, 2025—$700 million 4.550% due 2031 and $300 million 5.150% due 2036, guaranteed by parent entities. Net proceeds of ~$990 million target the pending Newfront acquisition and full repayment of $550 million 4.400% notes due 2026. If Newfront fails, proceeds repay those notes and redeem the 2036 tranche. Debt matures far out.
IPO
Website
Employees
Sector
Industry
AJG
Arthur J. Gallagher & Co.
251.98-4.21
AON
Aon plc
351.80-2.30
BNT
Brookfield Wealth Solutions Ltd
45.15-0.13
BRO
Brown & Brown, Inc.
80.97-1.36
BWIN
The Baldwin Insurance Group, In
22.34-1.33
HIG
The Hartford Insurance Group, I
137.77-0.90
MMC
Marsh & McLennan Companies, Inc
187.17-0.13
TIRX
TIAN RUIXIANG Holdings Ltd
0.55-0.04
TWFG
TWFG, Inc.
28.27-0.23
WTF
Waton Financial Limited
3.25+0.02